Oasis Diagnostics Corporation

Vancouver, WA Corporate

UEI
F63TP6A99PF3
CAGE
5XFE6
Primary NAICS
325413 In-Vitro Diagnostic Substance Manufacturing
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Self Certified Small Disadvantaged Business
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
15720 NE 31st Ave, Vancouver, WA 98686, USA
Website
4saliva.com
Founded
2002
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $0
FY2025 -$24,736

Contract vehicles

No active vehicles.

1 expired vehicle

Contract awards

Award Agency Obligated Awarded
Award a letter contract for radx tech - OASIS diagnostics corporation 75N92021C00006 National Heart Lung and Blood Institute (NIH) $7,654,382

Grant awards

Award Agency Obligated Awarded
Real-time salivary testosterone and extension to mobile application and multiple biomarker quantification capability R43DA043293 National Institute on Drug Abuse (NIH) $289,959
Verofy: a new tool to improve productivity and reduce costs for stress research R43AT006634 National Institutes of Health $325,567
Phase II of verofy: a new tool to improve productivity for stress research R44AT006634 National Center for Complementary and Integrative Health (NIH) $1,308,153

SBA capabilities narrative

From the vendor's SBA profile

Oasis Diagnostics Corporation develops saliva-based collection and testing technologies for non-invasive specimen analysis. The company manufactures cost-effective tools that collect, stabilize, store, and analyze saliva and urine specimens including proteins, DNA, RNA, cell-free DNA/RNA, exosomes, hormones, drugs of abuse, and metabolites.

Oasis technologies serve clinical, laboratory, research, field, and home-based settings across all age groups (infant to geriatric) plus veterinary applications. They enable rapid disease testing, early detection, and biomarker analysis using lateral flow immunoassays, mass spectrometry, next-generation sequencing, ELISA, and other laboratory techniques.

Key differentiators include proprietary purification processes producing clean specimens for immediate testing and advanced in-vitro diagnostic substance manufacturing. and broad accessibility across diverse testing environments.

Quick answers

Is Oasis Diagnostics Corporation registered in SAM.gov?

Yes. Oasis Diagnostics Corporation's SAM.gov registration is active through October 10, 2027.

Which contract vehicles does Oasis Diagnostics Corporation hold?

Oasis Diagnostics Corporation holds a place on 1 federal contract vehicle: FSS-65-VII.

What is Oasis Diagnostics Corporation's most recent federal award?

Oasis Diagnostics Corporation's most recent federal contract award is Award a letter contract for radx tech - OASIS diagnostics corporation (75N92021C00006), from National Heart Lung and Blood Institute (NIH), on January 8, 2021.

On GovTribe

See Oasis Diagnostics Corporation's full federal record

  • Federal contract awards
  • IDV awards
  • Contract vehicles
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login